TAGATOSE AS A NOVEL TREATMENT FOR METABOLIC SYNDROME X, DYSLIPIDEMIA, AND CORONARY ARTERY DISEASE

Details for Australian Patent Application No. 2002236854 (hide)

Owner UNIVERSITY OF MARYLAND, BALTIMORE

Inventors DONNER, Thomas

Pub. Number AU-A-2002236854

PCT Pub. Number WO2002/058710

Priority 60/263,949 25.01.01 US

Filing date 25 January 2002

Wipo publication date 6 August 2002

International Classifications

A61K 031/70 - Carbohydrates

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002236854

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002236855-T-SLOT MILLING CUTTER AND INSERT THEREFOR

2002236853-EFFICIENT BUFFER ALLOCATION FOR CURRENT AND PREDICTED ACTIVE SPEAKERS IN VOICE CONFERENCING SYSTEMS